DePuy Spine, Inc. Text SizeLarger TextMedium TextSmaller Text

  
AboutProductsProfessionalsPatientsCareersContact
Fact Sheet
           
Our Credo
           
Health Care Compliance
           
Principles of Collaboration
           
History
           
News & Press Releases
           
Alliance Companies
           
Locations / Directions




1895-1965 | 1968-1985 | 1987-1993 | 1994-1998 | 1999-Present


1987
DePuy and DuPont form a joint venture, DePuy DuPont Orthopaedics, to bring advanced materials to the orthopaedic marketplace. Its contributions include new Ultra High Molecular Weight Polyethylenes, Hylamer® and Hylamer-M, used as bearing materials in hip, knee and shoulder replacement surgery, and glove liners that help protect healthcare workers from sticks, cuts and punctures.

1990
Boehringer Mannheim purchases Charles F. Thackray Ltd. in Leeds, England. This acquisition brought together two of the world's leading manufacturers of total hip replacements. If DePuy's reputation was for pioneering biological fixation, Thackray's reputation was for its work with cement fixation. Working with the "father" of modern hip replacement surgery, Sir John Charnley, Thackray began manufacturing the Charnley Hip System in 1963.

Today, the Charnley Hip is the best selling cemented hip system in the world. Thackray now operates under the name DePuy International and serves as the headquarters outside the U.S., Canada and South America.

Mike McCaffrey is named president of DePuy, while Jim Lent takes over as chairman and CEO, DePuy Orthopaedics.

1991
DePuy acquires the Rotek Company in Albuquerque, New Mexico. DePuy began working with Rotek in 1980 when the fledgling company began manufacturing DePuy's environmental protection line. For ten years, DePuy was Rotek's single largest customer and in 1991, when the owner retired, DePuy acquired the company. Rotek now employs more than 100 people.

Bill Tidmore is appointed the position of president of DePuy International.

1992
DePuy enters into an alliance with biotechnology pioneer Genentech, Inc. Based in South San Francisco, California, Genentech developed the protein Transforming Growth Factor Beta One (TGF-B1) which shows promise in bone tissue growth and regeneration. DePuy and Genentech enters into an agreement to begin studying TGF-B1's use in orthopaedic applications.

Expanded Optics, a Westminster, California-based arthroscope manufacturer acquires Thackray-owned Scope Optics. DePuy, in turn, takes a 20 percent interest in Expanded Optics, moving DePuy into the fast- growing area of arthroscopic instruments and repair services.

DePuy is the fastest growing orthopaedics company.

DePuy Inc. is incorporated in Indiana.

1993
DePuy jointly forms a new company with Biedermann Motech, a spinal products manufacturer located in Schwennigen, Germany. The new company, DePuy Motech Inc., develops, manufactures and markets spinal implants. This marks DePuy's re-entry into the spinal implant market.

Mike Dormer becomes president of DePuy International.


1895-1965 | 1968-1985 | 1987-1993 | 1994-1998 | 1999-Present
         
© DePuy Spine, Inc. 2003-2008. All rights reserved. This site is published by DePuy Spine, Inc. which is solely responsible for its contents.
Terms of Use | Legal Notice | Privacy Policy | Contact Us | Sitemap
Safe Harbor Policy | California Health Care Compliance Information | J&J Ethical Code for R&D